Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 4
2004 1
2005 2
2007 3
2008 1
2009 3
2011 2
2013 1
2014 2
2015 4
2016 7
2017 3
2018 7
2019 3
2020 6
2021 2
2022 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Cole J, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Mannent LP, Patel N, Staudinger HW, Yancopoulos GD, Mortensen ER, Akinlade B, Maloney J, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM; BOREAS Investigators. Bhatt SP, et al. N Engl J Med. 2023 Jul 20;389(3):205-214. doi: 10.1056/NEJMoa2303951. Epub 2023 May 21. N Engl J Med. 2023. PMID: 37272521 Clinical Trial.
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, Trivedi R, St Rose E, Ballal S, McLaren J, Darken P, Aurivillius M, Reisner C, Dorinsky P; ETHOS Investigators. Rabe KF, et al. N Engl J Med. 2020 Jul 2;383(1):35-48. doi: 10.1056/NEJMoa1916046. Epub 2020 Jun 24. N Engl J Med. 2020. PMID: 32579807 Clinical Trial.
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
Menzies-Gow A, Wechsler ME, Brightling CE, Korn S, Corren J, Israel E, Chupp G, Bednarczyk A, Ponnarambil S, Caveney S, Almqvist G, Gołąbek M, Simonsson L, Lawson K, Bowen K, Colice G; DESTINATION study investigators. Menzies-Gow A, et al. Lancet Respir Med. 2023 May;11(5):425-438. doi: 10.1016/S2213-2600(22)00492-1. Epub 2023 Jan 23. Lancet Respir Med. 2023. PMID: 36702146 Clinical Trial.
Nucleoside Inhibitors of Coronaviruses.
Zenchenko AA, Drenichev MS, Mikhailov SN. Zenchenko AA, et al. Among authors: mikhailov sn. Curr Med Chem. 2021;28(26):5284-5310. doi: 10.2174/0929867328666210208181724. Curr Med Chem. 2021. PMID: 33563148 Review.
Poly(ADP-ribose): From chemical synthesis to drug design.
Drenichev MS, Mikhailov SN. Drenichev MS, et al. Among authors: mikhailov sn. Bioorg Med Chem Lett. 2016 Aug 1;26(15):3395-403. doi: 10.1016/j.bmcl.2016.06.008. Epub 2016 Jun 6. Bioorg Med Chem Lett. 2016. PMID: 27318540 Review.
Synthesis of N6 -Substituted Adenosines as Cytokinin Nucleosides.
Drenichev MS, Oslovsky VE, Tararov VI, Mikhailov SN. Drenichev MS, et al. Among authors: mikhailov sn. Curr Protoc Nucleic Acid Chem. 2018 Mar;72(1):14.15.1-14.15.16. doi: 10.1002/cpnc.49. Curr Protoc Nucleic Acid Chem. 2018. PMID: 29927122
Synthesis of 2'-O-beta-d-Ribofuranosylnucleosides.
Mikhailov SN, Efimtseva EV, Rodionov AA, Bobkov GV, Kulikova IV, Herdewijn P. Mikhailov SN, et al. Curr Protoc Nucleic Acid Chem. 2007 Jan;Chapter 1:Unit 1.14. doi: 10.1002/0471142700.nc0114s27. Curr Protoc Nucleic Acid Chem. 2007. PMID: 18428962
58 results